Revvity
Steven Hart is a seasoned professional in the medical diagnostics and engineering fields, currently serving as VP Global R&D - Diagnostics at Revvity since January 2023. Prior to this role, Steven held various positions at TB IDx, including SVP Operations and Product Development and Managing Director at Oxford Immunotec, alongside a significant tenure at SPD Swiss Precision Diagnostics from January 2005 to December 2022, where Steven rose to Managing Director. Early in Steven's career, roles included Senior Mechanical Engineer at Smiths Medical and Cambridge Mechatronics Ltd, as well as Mechanical Engineer at Allen Coding Systems. Steven's comprehensive experience encompasses leadership in operations, product development, and research and development within the healthcare industry.
This person is not in any teams
This person is not in any offices
Revvity
8 followers
At Revvity, “impossible” is inspiration, and ""can't be done"" is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. With more than $3 billion in revenue and over 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 190 countries. Learn more at www.revvity.com